rediff News http://www.rediff.com/tags/glaxo+arm+glaxo+india India's largest news and entertainment service online.. en-us Mon, 22 Dec 14 20:49:19 +0000 Mon, 22 Dec 14 20:49:19 +0000 http://www.rediff.com/push Rediff feeds Copyright: (C) 2009 Rediff.com India Limited. All Rights Reserved. <![CDATA[Sebi fines Glaxo for delayed disclosure in Indian listed arm]]> http://www.rediff.com/money/report/sebi-fines-glaxo-for-delayed-disclosure-in-indian-listed-arm/20141014.htm Tue, 23 Dec 2014 02:19:19 +0530 <![CDATA[Novartis-GSK-Eli Lilly deal may affect Indian market]]> http://www.rediff.com/money/report/novartis-gsk-eli-lilly-deal-may-affect-indian-market/20140423.htm Tue, 23 Dec 2014 02:19:19 +0530 <![CDATA['GSK-Novartis deal not to impact India business']]> http://www.rediff.com/money/report/gsk-novartis-deal-not-to-impact-india-business/20140422.htm Tue, 23 Dec 2014 02:19:19 +0530 <![CDATA[GSK raises stake in Indian arm to 72.5%]]> http://www.rediff.com/money/report/gsk-raises-stake-in-indian-arm-to-over-72-per-cent-deal-worth-rs-4800-crore/20130205.htm Tue, 23 Dec 2014 02:19:19 +0530 <![CDATA[GSK to spend $904 mn to lift stake in India arm]]> http://www.rediff.com/money/slide-show/slide-show-1-gsk-to-spend-usd-904-mn-to-lift-stake-in-india-arm/20121127.htm Tue, 23 Dec 2014 02:19:19 +0530 <![CDATA[And the award goes to...7 star performers of India Inc]]> http://www.rediff.com/money/report/pix-and-the-award-goes-tobest-ceos-who-have-made-india-inc-proud-/20141215.htm Tue, 23 Dec 2014 02:19:19 +0530 <![CDATA[Delicious Design Career in Food Processing]]> http://freepressjournal.in/delicious-design-career-in-food-processing/ Tue, 23 Dec 2014 02:19:19 +0530 <![CDATA[India Inc's growing disconnect between profits and dividends]]> http://smartinvestor.business-standard.com/market/Compnews-282235-Compnewsdet-India_Incs_growing_disconnect_between_profits_and_dividends.htm Tue, 23 Dec 2014 02:19:19 +0530 <![CDATA[Top 50]]> http://www.constructionweekonline.in/article-8395-top_50/ Tue, 23 Dec 2014 02:19:19 +0530 <![CDATA[Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic An...]]> http://www.andhranews.net/Intl/2014/Seattle-Genetics-Takeda-Announce-Four-Year-Survival-3556.htm Tue, 23 Dec 2014 02:19:19 +0530